Nuoxi (Lois) Li is an associate in Ropes & Gray’s corporate department. She advises public and private companies and investors on domestic and cross-border transactions, including mergers, stock and asset acquisitions and investments. She also advises clients on corporate governance and securities laws.

Experience

  • Represented Nuvalent, Inc. in its $10.6 billion sale to GSK plc.
  • Represented Eli Lilly and Company in its acquisition of Vaccine Company, Inc. for up to $1.55 billion.
  • Representing TriArtisan Capital Advisors portfolio company EnergySolutions, an international nuclear services company, in a definitive sale agreement to Energy Capital Partners.
  • Represented Stride Consumer Partners in its investment in Crown Affair, Inc., a hair care brand.
  • Represented Eli Lilly and Company in its $1.2 billion acquisition of Ventyx Biosciences, Inc.
  • Represented Nexthink SA, a category creator and leader in Digital Employee Experience (EDX) management, in connection with its $3 billion majority investment by Vista Equity Partners.
  • Represented a senior living provider in its sale of all assets.
  • Represented HP Inc. in its acquisition of key AI capabilities from Humane, including the AI-powered platform Cosmos.
  • Represented Eli Lilly and Company in its acquisition of Scorpion Therapeutics, Inc., immediately following a spin-off of Scorpion’s non-core assets, for up to $2.5 billion.
  • Represented The Duckhorn Portfolio, Inc., a luxury wine company, in its $1.95 billion sale to Butterfly Equity LP.
  • Represented ImmunoGen, Inc. in its $10.1 billion sale to AbbVie Inc.
  • Represented Johnson & Johnson in connection with various domestic and cross-border acquisitions and divestitures.
  • Represented LPL Financial, the nation’s largest independent broker-dealer network, in several strategic transactions of investment advisory and financial planning firms.
  • Represented a global medical technology company in its acquisition of a leading designer and manufacturer of fluid management systems for endoscopic procedures.
  • Represented a financial services company in several minority investments in investment advisory and financial planning firms.
  • Represented a special committee of the board of AlerisLife Inc. in connection with the sale of AlerisLife to ABP Acquisition LLC.